tradmap

ODTX Earnings Odyssey Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Chart & overview → Latest filing

Quarterly results

Diluted EPS (quarterly)
-$39 -$20 $0 Q1 '25 Q2 '25 Q1 '26 Q2 '26
EPS
Revenue (quarterly)
$0 $959000 $2M Q1 '25 Q2 '25 Q1 '26 Q2 '26
Revenue
Net income (quarterly)
-$53M -$26M $0 Q1 '25 Q2 '25 Q1 '26 Q2 '26
Net income

Reported EPS history

1–4 of 4
Q2 20262026-06-30-1.742026-08-0610-Q
Q1 20262026-03-31-6.772026-06-1710-Q
Q2 20252025-06-30-29.54——
Q1 20252025-03-31-39.37——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.